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Encapsulated Nanodroplet Crystallization of
Organic-Soluble Small Molecules
The routine crystallization of small molecules for single-crystal X-ray analysis
remains a considerable experimental challenge. We report a general method for
the high-throughput nanoscale crystallization of organic-soluble small molecules:
encapsulated nanodroplet crystallization (ENaCt). ENaCt provides crystals
suitable for X-ray analysis, allowing structural and de novo absolute
stereochemical assignment for a diverse and challenging range of small molecules
(bioactives, natural products, organometallics, etc.), as well as acting as a tool for
new polymorph discovery.
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X-ray diffraction analysis of
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Encapsulated Nanodroplet Crystallization
of Organic-Soluble Small Molecules
Andrew R. Tyler,1 Ronnie Ragbirsingh,1 Charles J. McMonagle,1 Paul G. Waddell,1 Sarah E. Heaps,2
Jonathan W. Steed,3 Paul Thaw,4 Michael J. Hall,1,5,* and Michael R. Probert1,*
SUMMARY
Single-crystal X-ray diffraction analysis (SCXRD) constitutes a universal
approach for the elucidation of molecular structure and the study of
crystalline forms. However, the discovery of viable crystallization
conditions remains both experimentally challenging and resource
intensive in both time and the quantity of analyte(s). We report a
robot-assisted, high-throughput method for the crystallization of
organic-soluble small molecules in which we employ only micrograms
of analyte per experiment. This allows hundreds of crystallization con-
ditions to be screened in parallel with minimal overall sample require-
ments. Crystals suitable for SCXRD are grown from nanoliter droplets
of a solution of analyte in organic solvent(s), each of which is encapsu-
latedwithin an inert oil to control the rate of solvent loss. This encapsu-
lated nanodroplet crystallization methodology can also be used to
search for new crystal forms, as exemplified through both our discov-
ery of a new (13th) polymorph of the olanzapine precursor ROY and
SCXRD analysis of the ‘‘uncrystallizable’’ agrochemical dithianon.
INTRODUCTION
Single-crystal X-ray diffraction (SCXRD) allows for the direct analysis of crystalline small
molecules, providing structural information with sub-A˚ngstrom resolution,1 de novo ab-
solute stereochemistry assignment (via anomalous dispersion),2 and detailed informa-
tion on intermolecular interactions and structural packing motifs. Modern in-house sin-
gle-crystal diffraction instrumentation (e.g., microfocus X-ray tubes, multi-layer
focusing optics, and very-low-noise area detectors) allows for the routine investigation
of crystals, containing only light atoms, with dimensionsz 50 mm.3 That, in combination
with improved access to synchrotron radiation sources (e.g., remote-access beamlines),4
has allowed SCXRD to become a ubiquitous research technique for molecular analysis,
given a suitable crystalline sample; as of 2019, over one million crystal structures have
been deposited in the Cambridge Crystallographic Data Centre (CCDC).5
Most small molecules are capable of existing as crystalline solids either as pure ma-
terials or in conjunction with other species (e.g., salts, hydrates, solvates, or co-crys-
tals)6 and thus are theoretically amenable to SCXRD analysis. However, the growth
of suitably sized, high-quality single crystals remains experimentally challenging in
that researchers still rely on time-consuming manual methods (i.e., solvent evapora-
tion, exchange, or diffusion experiments),7 which typically take many weeks to com-
plete and require milligrams of analyte per experiment.
Recently, a number of approaches have attempted to circumnavigate the problems
associated with traditional small-molecule crystal growth while retaining the
The Bigger Picture
Small molecules can form
crystalline solids, in which
individual molecules pack
together into ordered three-
dimensional arrays. Once a
suitable crystal is grown, the
packing and atomic connectivity
of the constituent molecules can
be studied by X-ray diffraction.
However, the discovery of
experimental conditions for
successful crystal growth is often
challenging. We have developed
a nanoscale crystallization
technique for organic-soluble
small molecules by using high-
throughput liquid-handling
robotics to undertake multiple
crystallization experiments
simultaneously with minimal
sample requirements and high
success rates. We showcase our
methodology through the
crystallization of a diverse set of
small molecules, including
‘‘uncrystallizables,’’ combined
with structural analysis by X-ray
diffraction. We anticipate that this
rapid and reliable method for
small-molecule crystallization will
have far-reaching impact,
facilitating academic and
industrial research in the
molecular sciences.
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analytical power provided by diffraction-based techniques. Fujita’s ‘‘crystalline
sponge’’ method relies on the long-range ordering of small organic ‘‘guest’’ mole-
cules within a single crystal of a pre-prepared porous host, and subsequent SCXRD
analysis of this host-guest complex provides structural information on the guest
molecule.8,9 However, as a result of weak host-guest interactions, the small-mole-
cule guest must be carefully paired with an appropriate host, and the physical sep-
aration of guest molecules precludes analysis of any potential intermolecular inter-
actions or other solid-state properties. Electron diffraction (e.g., MicroED) has
subsequently emerged as a technique for the analysis of crystalline small molecules,
where electron diffraction patterns are obtained from small single crystals (1–10 mm
in each dimension).10–12 However, the intensity of the electron beam causes rapid
sample degradation via in situ radical generation; the crystals must be stable within
the vacuum stage (precluding the study of hydrates and solvates), and the elucida-
tion of absolute stereochemistry is far from routine (e.g., dynamical refinement).13
Thus, SCXRD remains the analytical technique of choice for the study of small molecules,
although it is hampered by the practical constraints of crystal growth. Easy access to sin-
gle crystals, suitable for SCXRD, would therefore be a significant enabling step across
the molecular sciences. Solution-phase crystallization commences with nucleation
from a supersaturated solution followed by crystal growth.14 Nucleation is a stochastic
process that, especially in the case of heterogeneous nucleation, is heavily influenced
by the local environment (e.g., solvent[s], impurities, contact surfaces, and convection).
Therefore, control is required over both the conditions of supersaturation and the num-
ber of nucleation sites present. The solid-state energy landscape of a molecule can be
further complicated by the existence of multiple crystalline forms (e.g., salts, hydrates,
solvates, co-crystals, or polymorphs). Hence, the discovery of successful crystallization
conditions requires the exploration of large volumes of experimental space. Despite
considerable research into the development of new small-molecule crystallization tech-
niques, the current state of the art still requires the use ofmilligramsof analyte per exper-
iment or is restricted to specific molecular classes, limiting the experimentally accessible
envelope.15–18
Here, we discuss our use of high-throughput crystallization techniques as a general
method for the growth of single crystals of organic-soluble small molecules on the
nanoscale. Taking inspiration from ‘‘microbatch-under-oil’’ protein crystallization
techniques,19,20 our key enabling breakthrough involves the use of inert viscous
oils to control the rate of solvent loss from nanoliter-scale droplets of organic sol-
vent, each containing a fewmicrograms of small-molecule analyte. Oil encapsulation
results in a slow increase in sample concentration up to and beyond the point of satu-
ration, even for nanoliter-scale droplets of volatile organic solvents. When oil encap-
sulation is combined with the restricted number of nucleation sites available in such
small droplets, we observe the growth of high-quality single crystals with dimensions
R 20 mm. These crystals are shown to provide excellent X-ray diffraction data sets on
either in-house instrumentation or central facility beamlines.
We also show that encapsulated nanodroplet crystallization (ENaCt) experiments
can be efficiently set up via a suitable liquid-handling robot, resulting in a semi-auto-
mated experimental approach in which hundreds of individual crystallization exper-
iments can be initiated within a fewminutes. This high-throughput parallel screening
approach allows for rapid exploration of crystallization space and thus reliable ac-
cess to suitable crystals. This is demonstrated here through the successful crystalli-
zation and SCXRD analysis of 14 structurally diverse molecules, including de novo
absolute stereochemical analysis, polymorph discovery (including a hitherto
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unknown 13th polymorph of 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarboni-
trile [ROY], R18), and the crystallization of ‘‘uncrystallizable’’ substrates (dithianon).
RESULTS AND DISCUSSION
Preliminary Oil-Encapsulated Nanodroplet Crystallizations
Nanoscale crystallizations are typically incompatible with the use of analyte solutions
containing a high percentage of organic solvents because rapid solvent evaporation
leads to deposition of the analyte as amorphous material. The rate of evaporative
loss is proportional to the air-liquid interface surface area and is thus rapid in terms
of percentage volume for a nanoliter-scale droplet.
We postulated that the evaporative loss from a nanodroplet of organic solvent could
be slowed by reduction of the air-liquid interface surface area by encapsulation of
said nanodroplet within a droplet of oil. This slower, more controlled concentration
of the analyte would lead to improved crystal growth.
It should be noted that using oils to aid in the growth of single crystals for X-ray
diffraction analysis from aqueous buffer solutions is known in protein crystalliza-
tion19,20 and has recently been applied to the crystallization of highly water-soluble
salts of small organic molecules.21 However, this ‘‘microbatch-under-oil’’ approach
requires the use of aqueous solutions of water-soluble molecular analytes, typically
in combination with low-density, mobile paraffin oils, to ensure phase separation
while maintaining droplet mobility. These conditions are incompatible with most
small organic molecular analytes because of their poor solubility in the aqueous
buffers utilized, and the direct exchange of the aqueous buffer in such an experiment
with an organic solvent would make the maintenance of phase separation chal-
lenging. Therefore, we chose to focus on using viscous oils with low miscibility in
common organic solvents to encapsulate our organic nanodroplets, thus maintain-
ing droplet integrity and encapsulation of the analyte solution.
Furthermore, the oils utilized would have to exhibit low vapor pressures to prevent
evaporation and be chemically inert because of the anticipated long contact times
with the organic solvent utilized. Thus, we undertook a series of preliminary oil-
encapsulated nanodroplet crystallization experiments that involved using an SPT
Labtech mosquito liquid-handling robot to place 250 nL droplets of different
test oils into a 96-well glass plate (Laminex or SWISSSCI LCP 100-micron), into which
50 nL of a solution of a small organic molecule (ROY) in an appropriate organic sol-
vent was placed. ROY was chosen as a test substrate because of its propensity to
form distinctively colored crystals, facilitating visual analysis of the crystallization
process. The resulting 96-well plates were sealed (glass cover) and stored at room
temperature (RT), and each well was examined periodically for crystal formation
by polarizing light optical microscopy. After several days, we observed the formation
of large numbers of crystals, many of which were single crystals of sufficient dimen-
sions for SCXRD (Figure 1), providing the initial experimental support for our
research postulate (see Methods Video S1).
Comparison of Encapsulated versus Non-encapsulated Nanodroplet
Crystallizations
On the basis of these preliminary results, we attempted to further validate our experi-
mental design througha comparisonof organic-solvent-based nanodroplet crystallization
conditions with and without oil encapsulation by employing a set of five representative
small-molecule analytes: aspirin (1), caffeine (2), BODIPY (methyl 4-(5,5-difluoro-5H-
4l,45l4-dipyrrolo[1,2-c:20,10-f][1,3,2]diazaborinin-10-yl)benzoate) (3), (R)-BINOL (4), and
ll
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(S)-naproxen (5). An SPT Labtech mosquito liquid-handling robot was used to dispense
the first two test oils (50–300 nL of Fluorinert FC-40 and polydimethyl siloxane [PDMSO])
on a 96-well glass plate (Laminex or SWISSCI LCP100-micron) and then dispense 50 nL of
analyte solution in an organic solvent (40–50 mg/mL) either into the oil droplet or directly
onto the plate. Six solvents were chosen—acetone, ethyl acetate, ethanol, 1,2-dichloro-
ethane, N,N-dimethylformamide, and dimethyl sulfoxide—because they span a range
of boiling points (bp = 56C, 77C, 79C, 84C, 153C, and 189C) and polarities (ε =
21, 6, 35, 11, 38, and 46). For control experiments employing no oil, we added additional
solvent to give a total volume of 100–350 nL to maintain a comparable droplet size with
oil-encapsulated experiments and thus a similar solvent-air interface area. After the exper-
imental setup of the nanodroplets, the crystallization plates were partially sealed from at-
mospheric conditions with the use of a glass cover and stored at RT (see Supplemental
Experimental Procedures). After 1, 3, 7, and 14 days, we photographed and assessed in-
dividualwells by optical, cross-polarizing lightmicroscopy to establish thepresenceof sin-
gle crystals. We chose 14 days as a common end point for the experiments to provide a
balance between crystal formation and complete desolvation of the sample. Experi-
mental outcomes were categorized on a 1–5 scale (1 = no solid [still solvated]; 2 = phase
separation; 3 = solid [amorphous or microcrystalline]; 4 = small single crystals [<50 mm];
and 5 = large single crystals [>50 mm]) (Figure 2).
After 14 days, the majority of experiments had reached an end point (2–5). Visual in-
spection of the results showed that those crystallization conditions employing low-
boiling-point solvents (acetone, ethyl acetate, and ethanol) without oil encapsula-
tion had only given amorphous or microcrystalline solids resulting from the antici-
pated rapid evaporative solvent loss. Higher boiling solvents (1,2-dichloroethane,
dimethylformamide [DMF], and dimethyl sulfoxide [DMSO]) without oil encapsula-
tion did result in small numbers of single crystals (e.g., 4 in 1,2-dicholorethane),
and some samples remained in solution (e.g., DMSO). However, as a consequence
of more controlled solvent loss, oil encapsulation with both fluorous (FC-40) and
non-fluorous (PDMSO) oils improved the experimental outcomes for all solvents
examined such that many more small (4) and large (5) single crystals were observed.
Interestingly, the oil encapsulation of nanodroplets of DMSO analyte solutions
improved experimental outcomes, whereas non-encapsulated samples remained
in solution. This suggests that in the case of oil-encapsulated DMSO nanodroplets,
an additional route to crystal formation might be occurring (e.g., diffusional loss of
solvent into the oil or nucleation at the solvent-oil interface).
Figure 1. Cross-Section Schematic of an ENaCt Experiment (Top) and ENaCt Experiment with 200
nL Mineral Oil and 50 mg/mL ROY in DMSO (Bottom).
(1) Viscous inert oil dispensed onto a well of a 96-well glass plate, (2) solution of analyte in organic
solvent injected into an oil droplet, (3) evaporative solvent loss to supersaturation, (4) nucleation,
and (5) crystal growth. (A) solution of solvated analyte under oil, (B) evaporative solvent loss to
supersaturation, (C) onset of crystal growth, and (D) complete crystallization.
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To gain further insight into the impact of oil encapsulation on small-molecule crystal-
lization, we performed a statistical analysis of the experimental outcomes. We fitted
a proportional odds model for ordinal logistic regression in the Bayesian framework
to access the relationship between the response variable (experimental outcomes 1–
5) and the covariates (volume of solvent, volume of oil, type of solvent, type of oil,
and molecule).22 The use of oils, both FC-40 and PDMSO, showed a clear positive
relationship with the outcome of the crystallization experiments such that more suit-
able single crystals were formed under oil-encapsulation conditions (see Supple-
mental Experimental Procedures).
Figure 2. Encapsulated versus Non-encapsulated Nanodroplet Crystallizations
(A) Crystallization conditions for analytes 1–5 dissolved in organic solvents (acetone, ethyl acetate, ethanol, 1,2-dichoroethane, dimethylformamide, or
dimethyl sulfoxide) with and without oil encapsulation (FC-40 or PDMSO). (1) Red: sample remains in solution; (2) orange: phase separation from
solution and no solid; (3) yellow: amorphous or micro-crystalline solids; (4) light green: small single crystal(s); (5) dark green: large single crystal(s).
(B) Representative experimental outcomes (1–5) shown with BODIPY (3) for ease of visualization.
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Finally, suitable single crystals of each of the five compounds (1–5) were retrieved
from their corresponding 96-well plates, mounted, and analyzed by SCXRD. In all
cases, high-quality data were recorded to a minimum completeness of 99% at a min-
imum resolution of 0.84 A˚ on standard in-house diffractometers using Cu Ka X-radi-
ation (l = 1.54184 A˚). Molecular structures were then obtained through structure so-
lution and refinement using the OLEX223 interface to the SHELX24 suite of programs.
Furthermore, the absolute stereochemical assignments were confirmed by success-
ful refinement of the Flack parameter derived from anomalous dispersion measure-
ments for both 4 and 5 (Figure 3).
To further validate the capability of the ENaCt protocol, we subsequently applied it
to a broader set of chemical compounds (S1–S7). These experiments were further
refined through the addition of small volumes (up to 100 nL) of a secondary solvent
to the solution of analyte within the inert oil droplet and the use of a wider range of
inert oils, allowing an expansion of the protocol’s experimental space-sampling
capability through the fine-tuning of crystallization conditions. In all cases, suitable
single crystals were successfully grown and subsequently analyzed by SCXRD, result-
ing in full structure solution and refinement coupled with absolute stereochemical
assignments where appropriate (Figures S1 and S2).
Polymorph Screening of ROY
After the success of our previous crystallization experiments, we applied our ENaCt pro-
tocol to awell-knownproblem in solid-state chemistry, namely polymorphism. This is the
phenomenon where a given compound crystallizes into different solid phases—differing
only by the three-dimensional arrangement of molecules in space—that return to indis-
tinguishable solutionor liquid states.25 Thediscovery of polymorphic forms is particularly
suited to our ENaCt protocol because large numbers of crystallization experiments can
be undertaken in parallel (reducing the total number of person hours required) with well-
defined yet different crystallization conditions.
Polymorphism is particularly relevant to the pharmaceutical industry because
different polymorphs of a compound can have significantly different physical prop-
erties (e.g., solubility and stability). This is a particular concern for the preparation of
active pharmaceutical ingredients (APIs), where such physical properties directly
affect the bioavailability of a compound. Thus, the early identification of accessible
polymorphs of an API is of significant economic importance because an unexpected
appearance of a previously unknown stable polymorphic phase can result in tempo-
rary market withdrawal pending reformulation.26
We chose 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile (6), also
known as ROY because of the different colors (red, orange, and yellow) exhibited
by its various crystalline states. A synthetic precursor of the antipsychotic olanza-
pine, we envisaged this as an ideal test substrate for polymorph screening using
our high-throughput platform. Since the discovery of the first polymorphs of
ROY in 1998, it has been the target of numerous experimental and computational
studies focusing on new polymorph discovery and prediction. This has resulted in
12 published polymorphs, nine of which have been characterized by X-ray diffrac-
tion.27–30
In order to screen for new and existing polymorphs of ROY, we undertook a large
number of parallel experiments in which nanodroplets of ROY solutions were
encapsulated in a selection of inert oils. Individual experiments were checked for
crystal growth periodically, and the first single crystals appeared after 12 h.
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Suitable single crystals of ROY were obtained from a range of different experi-
mental conditions.
Four of the known ROY polymorphs (Y, R, ON, and ORP) can be accessed through
solution-phase crystal growth; the others arise directly or indirectly only via melt ex-
periments. By using our ENaCt protocol, we were able to grow single crystals suit-
able for SCXRD analysis for all four of the solution-phase accessible polymorphs,
where Y was the most commonly observed (Figure 4).
Figure 3. Molecular Structures, Electron Density Maps, and Refined Crystallographic Molecular
Models Derived from SCXRDAnalysis of Single Crystals of Compounds 1–5 Formed via the ENaCt
Protocol
Each structure is provided with selected crystallographic information.
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Additionally, deep-red block-shaped crystals of ROY were observed, and they did
not match the color, morphology profile, or unit cell of any of the known ROY poly-
morphs (Figure 5). Full structural investigation by SCXRD (150 K, in-house X-ray
diffractometer) confirmed this as a new ROY polymorph (R18) that had not previously
been reported experimentally and as only the second ROY polymorph to have a Z0
value > 1. R18 is the 13th polymorph of ROY to be discovered and the tenth to be
fully characterized through SCXRD, returning ROY to the status of world record hold-
er for the most polymorphic organic molecule.
Thus, the discovery of R18 further validates the power of the ENaCt protocol not just
as a crystallization method for X-ray analysis but also as a potential polymorph
screening tool.
Crystallization of an ‘‘Uncrystallizable’’ Molecule: Dithianon (7)
Finally, we wished to apply our ENaCt methodology to the crystallization of a crystallo-
graphically challenging or previously deemed ‘‘uncrystallizable’’ sample. We envisaged
that the high-throughput capability of ENaCt would allow for the rapid screening of the
diverse crystallization conditions required to ensure the growth of a single crystal suit-
able for X-ray diffraction analysis of such amaterial. To this end,we selected the function-
alized naphthoquinone dithianon (5,10-dioxo-5,10-dihydronaphtho[2,3-b][1,4]dithiine-
2,3-dicarbonitrile) (7). Dithianon was first introduced in 1963 as a broad-spectrum foliar
fungicide and is still used for controlling fungal infections in commercial agriculture.31
Dinnebier and co-workers have previously shown the existence of four different poly-
morphs of dithianon (forms 1–4) via refinement against high-resolution X-ray powder
diffraction data sets. However, they did not report a SCXRD data set because of ‘‘.
the lack of single crystals of sufficient size and quality’’ as a result of the lack of strong
intermolecular interactions in the solid state.32
Thus, following our ENaCt methodology, we undertook 384 individual crystallization
experiments. We dispensed 200 nL of oils (FC 40, Fomblin YR, PDMSO, or mineral
Figure 4. Molecular Structures, Crystal Growth Images, and SCXRD Data for Existing (Y, ON, ORP, and R) and New (R18) Polymorphs of ROY (6)
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oil), followed by 50 nL of dithianon solution (2–50 mg/mL of DMSO or DMF) and 25
or 50 nL of a secondary solvent (toluene, chlorobenzene, 2-methyl-2,4-pentanediol,
or water), into 96-well glass plates. After 14 days at RT, experiments were examined
by polarizing optical microscopy. 72 crystalline samples (19% of the total number)
exhibiting block-, plate-, and needle-like morphologies were identified, and a suit-
able block-like crystal was analyzed by SCXRD (Figure 5).
The structural model, derived from the SCRXD data, confirmed that we had success-
fully obtained a single crystal of dithianon (polymorph 1). The structure suffers from
minor disorder components, ascribed to stacking faults within the crystal. Further
analysis of the structure within the software package CrystalExplorer33 indicated
the presence of only a small number of weak intermolecular interactions within the
structure and no interlayer component of the total energy framework exceeding
15 kJmol1 (Figure S3). We propose that the presence of only weak interactions is
the cause of the previously failed dithianon crystallization attempts using traditional
methodologies. Thus, these experiments further demonstrate the capability of the
ENaCt protocol to address even the most challenging of crystallization problems.
Conclusion
There is a requirement across the molecular sciences for a widely applicable, high-
throughput crystallization method that operates on the microgram scale. The ENaCt
protocol described here fulfills these requirements as a tailor-made solution to the
crystallization problem. Our results—both the successful crystallization of a diverse
set of small molecules (including the ‘‘uncrystallizable’’ dithianon) and the explora-
tion of the polymorphs of ROY—provide strong evidence for the potential of ENaCt
as a general tool for the crystallization of organic-soluble small molecules. We antic-
ipate that such facile access to high-quality single crystals through the rapid sam-
pling of large areas of the solid-state energy landscape will provide significant future
benefits to the molecular science community.
EXPERIMENTAL PROCEDURES
Resource Availability
Lead Contact
Request for further information should be directed to and will be fulfilled by the Lead
Contact, Michael J. Hall (michael.hall@newcastle.ac.uk).
Materials Availability
This study did not generate new unique materials.
Figure 5. Molecular Structure, Crystal Growth Image, and SCXRD Data for Dithianon (7),
Polymorph 1, Including Selected Crystallographic Information and ENaCt Crystal Growth
Conditions
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Data and Code Availability
The accession numbers for the crystallographic data reported in this paper are
CCDC: 1944195–1944211 and 1968245. These data can be obtained free of charge
from the Cambridge Crystallographic Data Centre at https://www.ccdc.cam.ac.uk/
structures.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.chempr.
2020.04.009.
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